Publication

Article

Pharmacy Practice in Focus: Health Systems

March 2019
Volume8
Issue 2

Improving the Performance of Specialty Pharmacists in the Care of Patients With Pulmonary Arterial Hypertension

FACULTY:

James S. Kalus, PharmD, FASHP Director of Pharmacy Henry Ford Health System Detroit, Michigan

EDUCATIONAL OBJECTIVES:

At the completion of this activity, the participant will be able to:

  • Analyze the unaddressed gaps of reversal agents for direct oral anticoagulants (DOACs) and the risk of bleeding complications
  • Identify patients hwho are at high risk for major bleeding secondary to DOAC use
  • Examine current and emerging DOAC reversal agents and their safety and efficacy
  • Explore the role of the health-system pharmacist in ensuring optimal management of the patient with DOAC-associated bleeding and implementing standards of practice for reversal agents using clinical vignetttes.

TARGET AUDIENCE: Health-system pharmacists

ACTIVITY TYPE: Application

RELEASE DATE: March 15, 2019

EXPIRATION DATE: March 15, 2020

ESTIMATED TIME TO COMPLETE ACTIVITY: 2.0 hours

FEE: This lesson is offered for free at www.pharmacytimes.org.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Related Videos
Practice Pearl #1 Active Surveillance vs Treatment in Patients with NETs